IPI Resident Scholar Dr. Merrill Matthews describes some of the hurdles of prescription drug development, why the development of the Covid-19 vaccines is such a success story, and what we might learn from this experience. With comments by IPI president Tom Giovanetti.
March 4, 2021
IPI Policy Basics: Prescription Drug Development and the Miracle of the Covid-19 Vaccine(s) (Audio: Podcast)
2021_03_04 Policy Basics Prescription Drug Development